Search Results - "Klecker, Raymond W"

Refine Results
  1. 1

    Zebularine metabolism by aldehyde oxidase in hepatic cytosol from humans, monkeys, dogs, rats, and mice : Influence of sex and inhibitors by KLECKER, Raymond W, CYSYK, Richard L, COLLINS, Jerry M

    Published in Bioorganic & medicinal chemistry (2006)
    “…To aid in the clinical evaluation of zebularine, a potential oral antitumor agent, we initiated studies on the metabolism of zebularine in liver cytosol from…”
    Get full text
    Journal Article
  2. 2

    Pharmacogenetically driven patient selection for a first-in-human phase I trial of batracylin in patients with advanced solid tumors and lymphomas by Kummar, Shivaani, Gutierrez, Martin E., Anderson, Lawrence W., Klecker, Raymond W., Chen, Alice, Murgo, Anthony J., Doroshow, James H., Collins, Jerry M.

    Published in Cancer chemotherapy and pharmacology (01-10-2013)
    “…Purpose Batracylin (daniquidone), an ATP-insensitive topoisomerase I/II inhibitor, demonstrated wide interspecies variation in preclinical models consistent…”
    Get full text
    Journal Article
  3. 3

    Glucuronidation of 3′-Azido-3′-Deoxythymidine (Zidovudine) by Human Liver Microsomes: Relevance to Clinical Pharmacokinetic Interactions with Atovaquone, Fluconazole, Methadone, and Valproic Acid by Trapnell, Carol Braun, Klecker, Raymond W., Jamis-Dow, Carlos, Collins, Jerry M.

    Published in Antimicrobial Agents and Chemotherapy (01-07-1998)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Reversal of Adriamycin Resistance by Verapamil in Human Ovarian Cancer by Rogan, Alfred M., Hamilton, Thomas C., Young, Robert C., Klecker, Raymond W., Ozols, Robert F.

    “…The effectiveness of adriamycin in the treatment of ovarian cancer and other human tumors has been limited by the development of drug resistance. Verapamil, a…”
    Get full text
    Journal Article
  7. 7

    Evaluation of highly bound drugs: interspecies, intersubject, and related comparisons by Collins, Jerry M, Klecker, Jr, Raymond W

    Published in Journal of clinical pharmacology (01-09-2002)
    “…Free (unbound) drug is generally the pharmacologically relevant parameter for drug exposure. Thus, comparisons among species, among individuals, and in other…”
    Get full text
    Journal Article
  8. 8

    Radiosynthesis of [11C]paclitaxel by Ravert, Hayden T., Klecker Jr, Raymond W., Collins, Jerry M., Mathews, William B., Pomper, Martin G., Wahl, Richard L., Dannals, Robert F.

    “…[11C]paclitaxel, a potential solid tumor imaging agent, was synthesized by reacting [α‐11C]benzoyl chloride with the primary amine precursor of paclitaxel. The…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Distribution of 1-(2-Deoxy-2-fluoro-β-d-arabinofuranosyl) Uracil in Mice Bearing Colorectal Cancer Xenografts by Eiseman, Julie L., Brown-Proctor, Clive, Kinahan, Paul E., Collins, Jerry M., Anderson, Lawrence W., Joseph, Erin, Hamburger, Deborah R., Pan, Su-shu, Mathis, Chester A., Egorin, Merrill J., Klecker, Raymond W.

    Published in Clinical cancer research (01-10-2004)
    “…Purpose: In colorectal, breast, and head and neck cancers, response to 5-fluorouracil is associated with low expression of thymidylate synthase. In contrast,…”
    Get full text
    Journal Article
  12. 12

    Metabolism by N-Acetyltransferase 1 In Vitro and in Healthy Volunteers: A Prototype for Targeted Inhibition by Cantilena Jr, Louis R., Katki, Aspandiar G., Klecker, Raymond W., Collins, Jerry M.

    Published in Journal of clinical pharmacology (01-12-2004)
    “…Inhibition of drug metabolism is generally avoided but can be useful in limited circumstances, such as reducing the formation of toxic metabolites. Acetylation…”
    Get full text
    Journal Article
  13. 13

    Suicide Prodrugs Activated by Thymidylate Synthase: Rationale for Treatment and Noninvasive Imaging of Tumors with Deoxyuridine Analogues by COLLINS, J. M, KLECKER, R. W, KATKI, A. G

    Published in Clinical cancer research (01-08-1999)
    “…Most tumors are resistant to therapy by thymidylate synthase (TS) inhibitors due to their high levels of TS. Instead of inhibiting TS, we hypothesized that it…”
    Get full text
    Journal Article
  14. 14

    Plasma and cerebrospinal fluid pharmacokinetics of 3'-azido-3'-deoxythymidine: a novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases by Klecker, Jr, R W, Collins, J M, Yarchoan, R, Thomas, R, Jenkins, J F, Broder, S, Myers, C E

    Published in Clinical pharmacology and therapeutics (01-04-1987)
    “…We investigated the clinical pharmacokinetics of azidothymidine (N3TdR) as part of a phase I/II trial in the treatment of acquired immunodeficiency syndrome…”
    Get more information
    Journal Article
  15. 15

    Evaluation of Highly Bound Drugs: Interspecies, Intersubject, and Related Comparisons by Collins, Jerry M., Klecker Jr, Raymond W.

    Published in Journal of clinical pharmacology (01-09-2002)
    “…Free (unbound) drug is generally the pharmacologically relevant param eter for drug exposure. Thus, comparisons among species, among individuals, and in other…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Thymidine phosphorylase as a target for imaging and therapy with thymine analogs by KLECKER, Raymond W, COLLINS, Jerry M

    Published in Cancer chemotherapy and pharmacology (01-11-2001)
    “…Thymidine phosphorylase (TPase; platelet-derived endothelial cell growth factor) is an attractive target for imaging and therapy because of the strong…”
    Get full text
    Journal Article
  18. 18

    Stereoselective Metabolism of Fenoldopam and Its Metabolites in Human Liver Microsomes, Cytosol, and Slices by Klecker, Raymond W, Collins, Jerry M

    Published in Journal of cardiovascular pharmacology (01-07-1997)
    “…Fenoldopam is a racemic mixture (R-FEN, S-FEN) that is a selective dopamine (DA-1) receptor agonist with pronounced cardiovascular and renal effects in humans…”
    Get full text
    Journal Article
  19. 19

    Effect of the mutation of tyrosine 713 in p93c-fes on its catalytic activity and ability to promote myeloid differentiation in K562 cells by Fang, Fang, Ahmad, Shakeel, Lei, Jun, Klecker, Raymond W, Trepel, Jane B, Smithgall, Thomas E, Glazer, Robert I

    Published in Biochemistry (Easton) (13-07-1993)
    “…The protooncogene protein-tyrosine kinase c-fes plays an active role in the induction of terminal myeloid differentiation in myeloid leukemia cells. Although…”
    Get full text
    Journal Article
  20. 20

    Selenium-induced cytotoxicity of human leukemia cells: interaction with reduced glutathione by BATIST, G, KATKI, A. G, KLECKER, R. W. JR, MYERS, C. E

    Published in Cancer research (Chicago, Ill.) (01-11-1986)
    “…Selenium exists in a number of forms with differing valence states, some of which have shown antitumor activity. We studied the tumoricidal activity of four…”
    Get full text
    Journal Article